{"id":919,"date":"2022-06-28T11:35:50","date_gmt":"2022-06-28T14:35:50","guid":{"rendered":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/?page_id=919"},"modified":"2022-10-28T10:21:33","modified_gmt":"2022-10-28T13:21:33","slug":"programacao-auditorio-principal","status":"publish","type":"page","link":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/programacao-auditorio-principal\/","title":{"rendered":"Main Auditorium Programming"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"919\" class=\"elementor elementor-919\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-17e3979 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"17e3979\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f9fb8c8\" data-id=\"f9fb8c8\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-575e8d4 elementor-widget elementor-widget-heading\" data-id=\"575e8d4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Main Auditorium Programming<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ff07da4 elementor-widget elementor-widget-spacer\" data-id=\"ff07da4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-118a51f elementor-tabs-view-horizontal elementor-widget elementor-widget-tabs\" data-id=\"118a51f\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"programacao\" data-widget_type=\"tabs.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-tabs\">\n\t\t\t<div class=\"elementor-tabs-wrapper\" role=\"tablist\" >\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1831\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"true\" data-tab=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"elementor-tab-content-1831\" aria-expanded=\"false\">October, 30th<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1832\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1832\" aria-expanded=\"false\">October, 31th<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1833\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1833\" aria-expanded=\"false\">November, 1st<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<div class=\"elementor-tabs-content-wrapper\" role=\"tablist\" aria-orientation=\"vertical\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"true\" data-tab=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"elementor-tab-content-1831\" aria-expanded=\"false\">October, 30th<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1831\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1831\" tabindex=\"0\" hidden=\"false\"><div><div><div><h5><button type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: THEORETICAL BASIS OF THE TREATMENT OF PERITONEAL CARCINOMATOSIS<\/button><\/h5><p><strong>Moderator: Carlos Humberto Cereser Junior (RS)<\/strong><\/p><\/div><\/div><table><tbody><tr><td width=\"200\"><strong>13:30 \u00e0s 13:50<\/strong><\/td><td style=\"text-align: left;\"><strong>The theoretical basis of HIPEC- associated Cytoreduction<\/strong><br \/>Speaker: Paul Sugarbaker (USA)<\/td><\/tr><tr><td><strong>13:50 \u00e0s 14:10<\/strong><\/td><td style=\"text-align: left;\"><p><strong>Grounding in technological perspectives in PIPAC<\/strong><\/p><p>Speaker: Rafael Seitenfus (RS)<\/p><\/td><\/tr><\/tbody><\/table><div>\u00a0<\/div><div><div aria-labelledby=\"headingTwo\" data-parent=\"#accordionExample\"><h5><button type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: PSEUDOMYXOMA PERITONEI<\/button><\/h5><p><strong>Moderator: Hor\u00e1cio No\u00e9 L\u00f3pez Basave (M\u00e9xico)<\/strong><\/p><table style=\"height: 360px;\" width=\"968\"><tbody><tr><td width=\"200\"><strong>14:10 \u00e0s 14:30<\/strong><\/td><td style=\"text-align: left;\"><strong>Is free opioid technique in cytoreduction associated with HIPEC a reality?<\/strong><br \/>Speaker: Li\u00e9ge Immich (RS)<\/td><\/tr><tr><td><strong>14:30 \u00e0s 14:50<\/strong><\/td><td style=\"text-align: left;\"><strong>And selection of patients for extensive cytoreduction in peritoneal\npseudomyxoma<\/strong><br \/>Speaker: Tarc\u00edsio Cysneiros Reis (PE)<\/td><\/tr><tr><td><strong>14:50 \u00e0s 15:10<\/strong><\/td><td style=\"text-align: left;\"><strong>Current practices in HIPEC-associated cytoreduction in peritoneal pseudomyxoma<\/strong><br \/>Speaker: Carlos V\u00e9o (SP)<\/td><\/tr><tr><td><strong>15:10 \u00e0s 15:30<\/strong><\/td><td style=\"text-align: left;\"><strong>HIPEC chemotherapy regimens in the initial approach and in the recurrence of peritoneal pseudomyxomas<\/strong><br \/>Palestrante: Ignace de Hingh (Holanda)<\/td><\/tr><tr><td><strong>15:30 \u00e0s 15:50<\/strong><\/td><td style=\"text-align: left;\"><strong>Pseudomixoma peritoneal: Building a European Multicentrical Cohort to Accelerate New Therapeutic Perspectivs<\/strong><br \/>Palestrante: Marcello Deraco (It\u00e1lia)<\/td><\/tr><tr><td><strong>15:50 \u00e0s 16:10<\/strong><\/td><td style=\"text-align: left;\"><strong>Discuss\u00e3o:<\/strong>\u00a0Patr\u00edcia da Costa C\u00e2mara (SC) e Jos\u00e9 Pio Furtado (RS)<\/td><\/tr><tr><td><strong>16:10 \u00e0s 16:30<\/strong><\/td><td style=\"text-align: left;\"><strong>Break<\/strong><\/td><\/tr><\/tbody><\/table><h5>\u00a0<\/h5><h5><button type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: PSEUDOMYXOMA PERITONEI<\/button><\/h5><p><b>Moderador: Leonaldson do Santos Castro (RJ)<\/b><\/p><\/div><\/div><\/div><table style=\"height: 277px;\" width=\"1059\"><tbody><tr><td width=\"200\">16:30 \u00e0s 16:50<\/td><td style=\"text-align: left;\"><strong>Technical strategies for cytoreduction in challenging scenarios( high PCI)<\/strong><br \/>Speaker: Paul Sugarbaker (USA)<\/td><\/tr><tr><td>16:50 \u00e0s 17:10<\/td><td style=\"text-align: left;\"><strong>Maximal tumor debulking and HIPEC in two strokes \u2013 a possible reality?<\/strong><br \/>Palestrante: Andrea Petruzziello (PR)<\/td><\/tr><tr><td>17:10 \u00e0s 17:30<\/td><td style=\"text-align: left;\">O desafio da citorredu\u00e7\u00e3o associada \u00e0 HIPEC em cen\u00e1rios n\u00e3o CCO<br \/>Palestrante: Daniel Paulino Santana (MG)<\/td><\/tr><tr><td>17:30 \u00e0s 17:50<\/td><td style=\"text-align: left;\"><strong>A non-appendicular peritoneal pseudomyxoma: what is the role of HIPEC?<\/strong><br \/>Palestrante: Olivier Glehen (Fran\u00e7a)<\/td><\/tr><tr><td>17:50 \u00e0s 18:10<\/td><td style=\"text-align: left;\"><strong>Selecionando o paciente ideal para Re-HIPEC<\/strong><br \/>Palestrante: Beate Rau (Alemanha)<\/td><\/tr><tr><td>18:00 to 18:20<\/td><td style=\"text-align: left;\"><strong>Discuss\u00e3o:<\/strong>\u00a0Carlos Cereser Jr (RS), Eduardo Zanella (SC) e Lucas Torelly Fillippi (RS)<\/td><\/tr><tr><td>18:30 to 19:00<\/td><td style=\"text-align: left;\"><strong>Cocktail<\/strong><\/td><\/tr><tr><td>19:00 to 19:20<\/td><td style=\"text-align: left;\"><strong>Official Opening of the Congress<\/strong><\/td><\/tr><tr><td>19:20 to 19:40<\/td><td style=\"text-align: left;\"><strong>Present, past and future in the treatment of peritoneal carcinomatosis<\/strong><br \/>Speaker: Paul Sugarbaker (USA)<\/td><\/tr><tr><td>19:40 to 20:20<\/td><td style=\"text-align: left;\"><strong>Presentation of the male choir of Bom Principio<\/strong><\/td><\/tr><\/tbody><\/table><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1832\" aria-expanded=\"false\">October, 31th<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1832\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"2\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1832\" tabindex=\"0\" hidden=\"hidden\"><div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<h5 class=\"mb-0\"><button class=\"btn btn-link\" type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: PERITONAL MESOTHELIOMA<\/button><\/h5>\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"collapseTwo\" class=\"collapse\" aria-labelledby=\"headingTwo\" data-parent=\"#accordionExample\">\n<p><strong>Moderador: Francisco Perrota (Paraguai)<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<table style=\"height: 277px;\" width=\"1059\">\n<tbody>\n<tr>\n<td width=\"200\">08:00 to 08:20<\/td>\n<td style=\"text-align: left;\"><strong>Clinical and histological selection of mesothelioma for cytoreduction associated\nwith HIPEC<\/strong><br>Palestrante: Artur Reis (SP)<\/td>\n<\/tr>\n<tr>\n<td>08:20 to 08:40<\/td>\n<td style=\"text-align: left;\"><strong>Evaluation of different options for peritoneal perfusion regimens in mesothelioma<\/strong><br>Speaker: Paul Sugarbaker (USA)<\/td>\n<\/tr>\n<tr>\n<td>08:40 to 09:00<\/td>\n<td style=\"text-align: left;\"><strong>The possibility of large wall resections in HIPEC-associated cytoreduction<\/strong><br>Palestrante: Paulo Cesar Leonardi (SP)<\/td>\n<\/tr>\n<tr>\n<td>09:00 to 09:20<\/td>\n<td style=\"text-align: left;\"><strong>Total vs Selective Peritonectomy: What to do in Benign Multicystic Mesothelioma?<\/strong><br>Palestrante: Marcello Deraco (It\u00e1lia)<\/td>\n<\/tr>\n<tr>\n<td>09:20 \u00e0s 09:35<\/td>\n<td style=\"text-align: left;\"><strong>Alternatives to the non- candidate patient in curative surgical treatment<\/strong><br>Palestrante: Alexei Peter (RS)<\/td>\n<\/tr>\n<tr>\n<td>09:35 \u00e0s 09:45<\/td>\n<td style=\"text-align: left;\"><strong>Is PIPAC in Mesothelioma an Alternative?<\/strong><br>Palestrante: Muhammad Alyami (Ar\u00e1bia Saudita)<\/td>\n<\/tr>\n<tr>\n<td>09:45 \u00e0s 10:00<\/td>\n<td style=\"text-align: left;\"><strong>Discussion: Claudio Quadros (BH) and Elio Barreto (RN)<\/strong><\/td>\n<\/tr>\n<tr>\n<td>10:00 to 10:20<\/td>\n<td style=\"text-align: left;\"><strong>Break<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"collapseTwo\" class=\"collapse\" aria-labelledby=\"headingTwo\" data-parent=\"#accordionExample\">\n<h5>&nbsp;<\/h5>\n<h5 class=\"mb-0\"><button class=\"btn btn-link\" type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: HIPEC IN SUS (NHS) \u2013 WHERE WE COME FROM AND WHERE WE ARE GOING<\/button><\/h5>\n<p><strong>Moderador: Rafael Seitenfus (RS)<\/strong><\/p>\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<table style=\"height: 277px;\" width=\"1059\">\n<tbody>\n<tr>\n<td width=\"200\">10:20 to 10:40<\/td>\n<td style=\"text-align: left;\"><strong>Incorporation of HIPEC into SUS(NHS), a victory for the patient?<\/strong><br>Palestrante: Claudio Quadros (BA)<\/td>\n<\/tr>\n<tr>\n<td>10:40 to 11:00<\/td>\n<td style=\"text-align: left;\"><strong>Protocol construction for conitec: my experience<\/strong><br>Palestrante: Elio Barreto (RN)<\/td>\n<\/tr>\n<tr>\n<td>11:00 \u00e0s 11:10<\/td>\n<td style=\"text-align: left;\"><strong>The initial experience as a reference center<\/strong><br>Palestrante: Paulo Cesar Leonardi (SP)<\/td>\n<\/tr>\n<tr>\n<td>11:10 \u00e0s 11:40<\/td>\n<td style=\"text-align: left;\"><strong>Discuss\u00e3o:<\/strong> Tarc\u00edsio Cysneiros Reis (PE) and Carlos V\u00e9o (SP)<\/td>\n<\/tr>\n<tr>\n<td>11:40 to 12:00<\/td>\n<td style=\"text-align: left;\">Cerim\u00f4nia Entrega da 55\u00ba Legislatura da Assembleia Legislativa Ga\u00facha ao Dr Rafael Seitenfus<\/td>\n<\/tr>\n<tr>\n<td>12:00 \u00e0s 13:10<\/td>\n<td style=\"text-align: left;\"><strong>Lunch break<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h5>&nbsp;<\/h5>\n<h5>&nbsp;<\/h5>\n<h5 class=\"mb-0\"><button class=\"btn btn-link\" type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: PERITONEAL CARCINOMATOSIS OF COLONRETAL ORIGIN<\/button><\/h5>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"collapseTwo\" class=\"collapse\" aria-labelledby=\"headingTwo\" data-parent=\"#accordionExample\">\n<p><strong>Moderadora: Beate Rau (Alemanha)<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<table style=\"height: 277px;\" width=\"1059\">\n<tbody>\n<tr>\n<td width=\"200\">13:10 \u00e0s 13:30<\/td>\n<td style=\"text-align: left;\"><strong>Selecting the best patient for HIPEC-associated cytoreduction in colonrectal\ncarcinomatosis<\/strong><br>Palestrante: Eduardo Akaishi (SP)<\/td>\n<\/tr>\n<tr>\n<td>13:30 \u00e0s 13:50<\/td>\n<td style=\"text-align: left;\"><strong>Cytoreduction associated with HIPEC still has room after Prodige 7<\/strong><br>Palestrante: Victor Verwaal (Su\u00e9cia)<\/td>\n<\/tr>\n<tr>\n<td>13:50 \u00e0s 14:10<\/td>\n<td style=\"text-align: left;\"><strong>Is HIPEC-associated Colon cytoreduction for a high-risk patient still a possibility?<\/strong><br>Palestrante: Olivier Glehen (Fran\u00e7a)<\/td>\n<\/tr>\n<tr>\n<td>14:10 \u00e0s 14:20<\/td>\n<td style=\"text-align: left;\"><strong>Should molecular factors and MSI status modify our strategy in the treatment of colorectal metastasis?&nbsp;<\/strong><br>Palestrante: Claudio Quadros (BA)<\/td>\n<\/tr>\n<tr>\n<td>14:20 \u00e0s 14:30<\/td>\n<td style=\"text-align: left;\"><strong>Caso Clinico <\/strong><br>Palestrante: Marcos Lyra (BA)<\/td>\n<\/tr>\n<tr>\n<td>14:30 \u00e0s 14:50<\/td>\n<td style=\"text-align: left;\"><strong>Discuss\u00e3o: Felipe Augusto Cruz Lopes (PE), Fabio Lopes (MG) e Antonio Dal Pizzol Junior (RS)<\/strong><\/td>\n<\/tr>\n<tr>\n<td>14:50 \u00e0s 15:10<\/td>\n<td style=\"text-align: left;\"><strong>What to expect when using PIPAC as an alternative in the treatment of colon\ncarcinomatosis?<\/strong><br>Palestrante: Ignace de Hingh (Holanda)<\/td>\n<\/tr>\n<tr>\n<td>15:10 \u00e0s 15:30<\/td>\n<td style=\"text-align: left;\"><strong>What to expect when using systemic chemotherapy in the treatment of colon\ncarcinomatosis?<\/strong><br>Palestrante: Rafael Jos\u00e9 Vargas Alves (RS)<\/td>\n<\/tr>\n<tr>\n<td>15:30 \u00e0s 15:50<\/td>\n<td style=\"text-align: left;\"><strong>Break<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"collapseTwo\" class=\"collapse\" aria-labelledby=\"headingTwo\" data-parent=\"#accordionExample\">\n<h5>&nbsp;<\/h5>\n<h5 class=\"mb-0\"><button class=\"btn btn-link\" type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: CARCINOMATOSIS OF COLON ORIGIN<\/button><\/h5>\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"collapseTwo\" class=\"collapse\" aria-labelledby=\"headingTwo\" data-parent=\"#accordionExample\">\n<p><strong>Moderadores: Victor Verwaal (Su\u00e9cia)<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<table style=\"height: 277px;\" width=\"1059\">\n<tbody>\n<tr>\n<td width=\"200\">15:50 \u00e0s 16:10<\/td>\n<td style=\"text-align: left;\"><strong>Is the presence of extraperitoneal metastasis a contraindication to curative treatment?<\/strong><br>Palestrante: Olivier Glehen (Fran\u00e7a)<\/td>\n<\/tr>\n<tr>\n<td>16:10 \u00e0s 16:30<\/td>\n<td style=\"text-align: left;\"><strong>Could a study analyzing tumor sensitivity to systemic chemotherapy change our daily practice?<\/strong><br>Palestrante: Cl\u00e1udio Quadros (BA)<\/td>\n<\/tr>\n<tr>\n<td>16:30 \u00e0s 16:50<\/td>\n<td style=\"text-align: left;\"><strong>Discuss\u00e3o:<\/strong> F\u00e1bio Lopes (MG), Eduardo Akaishi (SP) e Rodrigo Guedes (BA)<\/td>\n<\/tr>\n<tr>\n<td>16:50 \u00e0s 17:20<\/td>\n<td style=\"text-align: left;\"><strong>I remember this complication<\/strong><br>Paul Sugarbaker (EUA), Beate Rau (Alemanha), Victor Verwaal (Su\u00e9cia)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"collapseTwo\" class=\"collapse\" aria-labelledby=\"headingTwo\" data-parent=\"#accordionExample\">&nbsp;<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1833\" aria-expanded=\"false\">November, 1st<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1833\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"3\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1833\" tabindex=\"0\" hidden=\"hidden\"><h5 class=\"mb-0\"><button class=\"btn btn-link\" type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: OVARIAN NEOPLASIA<\/button><\/h5>\n<p><strong>Moderador: Olivier Glehen (Fran\u00e7a)<\/strong><\/p>\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<table style=\"height: 277px;\" width=\"1059\">\n<tbody>\n<tr>\n<td width=\"200\">08:30 \u00e0s 08:50<\/td>\n<td style=\"text-align: left;\"><strong>HIPEC in ovarian cancer: optimal clinical scenarios and role of molecular profiling<\/strong><br>Palestrante: Gustavo Andreazza Laporte (RS)<\/td>\n<\/tr>\n<tr>\n<td>08:50 \u00e0s 09:10<\/td>\n<td style=\"text-align: left;\"><strong>Role of cytoreductive surgery for recurrent ovarian cancer<\/strong><br>Speaker: Rafael Seitenfus (RS)<\/td>\n<\/tr>\n<tr>\n<td>09:10 \u00e0s 09:30<\/td>\n<td style=\"text-align: left;\"><strong>What did we learn after 3 randomized trials? (OVHIPEC, Spanish and Korean)<\/strong><br>Palestrante: Olivier Glehen (Fran\u00e7a)<\/td>\n<\/tr>\n<tr>\n<td>09:30 \u00e0s 09:50<\/td>\n<td style=\"text-align: left;\"><strong>Discuss\u00e3o:<\/strong> Juan Medina (M\u00e9xico) e Carlos Martinez Marins (RJ)<\/td>\n<\/tr>\n<tr>\n<td>09:50 \u00e0s 10:10<\/td>\n<td style=\"text-align: left;\"><strong>Major advances in ovarian cancer maintenance therapies<\/strong><br>Palestrante: Antonio Dal Pizzol (RS)<\/td>\n<\/tr>\n<tr>\n<td>10:10 \u00e0s 10:30<\/td>\n<td style=\"text-align: left;\"><strong>Particularities of primary peritoneal serous adenocarcinoma of the ovary<\/strong><br>Palestrante: Marcello Deraco (It\u00e1lia)<\/td>\n<\/tr>\n<tr>\n<td>10:30 \u00e0s 10:50<\/td>\n<td style=\"text-align: left;\"><b>Break<\/b><\/td>\n<\/tr>\n<tr>\n<td>10:50 \u00e0s 11:10<\/td>\n<td style=\"text-align: left;\"><strong>Does PIPAC have a role in ovarian cancer?<\/strong><br>Palestrante: Olivier Glehen (Fran\u00e7a)<\/td>\n<\/tr>\n<tr>\n<td>11:10 \u00e0s 11:30<\/td>\n<td style=\"text-align: left;\"><strong>Discuss\u00e3o:<\/strong> Gustavo Andreazza Laporte (RS) e Patr\u00edcia da Costa C\u00e2mara (SC)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h5>&nbsp;<\/h5>\n<h5 class=\"mb-0\"><button class=\"btn btn-link\" type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESSION: CARCINOMATOSIS OF GASTRIC ORIGIN<\/button><\/h5>\n<p><strong>Moderador: Antonio Calos Weston (RS)<\/strong><\/p>\n<div id=\"accordionExample\" class=\"accordion\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<div class=\"card\">\n<div id=\"headingOne\" class=\"card-header\">\n<table style=\"height: 277px;\" width=\"1059\">\n<tbody>\n<tr>\n<td width=\"200\">11:30 \u00e0s 11:50<\/td>\n<td style=\"text-align: left;\"><strong>Immunonutrition in HIPEC<\/strong><br>Palestrante: Vict\u00f3ria Marzag\u00e3o (PR)<\/td>\n<\/tr>\n<tr>\n<td>11:50 \u00e0s 12:10<\/td>\n<td style=\"text-align: left;\"><strong>What do we learn from the German randomized trial for peritoneal metastasis from gastric cancer?<\/strong><br>Palestrante: Beate Rau (Alemanha)<\/td>\n<\/tr>\n<tr>\n<td>12:10 \u00e0s 12:30<\/td>\n<td style=\"text-align: left;\"><strong>What is the ideal patient for prophylactic and curative HIPEC in gastric cancer?<\/strong><br>Palestrante: Olivier Glehen (Fran\u00e7a)<\/td>\n<\/tr>\n<tr>\n<td>12:30 \u00e0s 14:10<\/td>\n<td style=\"text-align: left;\"><strong>Break<\/strong><\/td>\n<\/tr>\n<tr>\n<td>14:10 \u00e0s 14:30<\/td>\n<td style=\"text-align: left;\"><strong>Outcomes of perioperative intraperitoneal chemotherapy in peritoneal metastasis of gastric cancer?<\/strong><br>Palestrante: Eduardo Akaishi (SP)<\/td>\n<\/tr>\n<tr>\n<td>14:30 \u00e0s 14:50<\/td>\n<td style=\"text-align: left;\"><strong>Discuss\u00e3o:<\/strong> Bruno Sarmento (DF), Andr\u00e9 Maciel da Silva (RJ) e Carlos Cereser (RS)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p><button class=\"btn btn-link\" type=\"button\" data-toggle=\"collapse\" data-target=\"#collapseOne\" aria-expanded=\"true\" aria-controls=\"collapseOne\">SESS\u00c3O: CARCINOMATOSE DE ORIGEM G\u00c1TRICA&nbsp;<\/button><\/p>\n<p><strong>Moderador: Andr\u00e9 Maciel da Silva (RJ)<\/strong><\/p>\n<div id=\"headingOne\" class=\"card-header\">\n<table style=\"height: 277px;\" width=\"1059\">\n<tbody>\n<tr>\n<td width=\"200\">14:50 \u00e0s 15:10<\/td>\n<td style=\"text-align: left;\"><strong>How PIPAC can change the approach to carcinomatosis in stomach cancer<\/strong><br>Palestrante: Mohammad Alyami (Ar\u00e1bia saudita)<\/td>\n<\/tr>\n<tr>\n<td>15:10 \u00e0s 15:30<\/td>\n<td style=\"text-align: left;\"><strong>What is the best intraperitoneal chemotherapy regimen in HIPEC?<\/strong><br>Palestrante: Olivier Glehen (Fran\u00e7a)<\/td>\n<\/tr>\n<tr>\n<td>15:30 \u00e0s 15:50<\/td>\n<td style=\"text-align: left;\"><strong>Systemic chemotherapy in gastric cancer<\/strong><br>Palestrante: Livia Gravina (PR)<\/td>\n<\/tr>\n<tr>\n<td>15:50 \u00e0s 16:10<\/td>\n<td style=\"text-align: left;\"><strong>Discuss\u00e3o:<\/strong> Arnaldo Urbano Ruiz (SP) e Raul Anselmi (PR)<\/td>\n<\/tr>\n<tr>\n<td>16:10 \u00e0s 16:30<\/td>\n<td style=\"text-align: left;\"><strong>Break<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<p><strong>Moderadora: Beate Rau (Alemanha)<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"headingOne\" class=\"card-header\">\n<table style=\"height: 277px;\" width=\"1059\">\n<tbody>\n<tr>\n<td width=\"200\">16:30 \u00e0s 16:50<\/td>\n<td style=\"text-align: left;\"><strong>Latin registration<\/strong><br>Palestrante: Claudio Quadros (BA)<\/td>\n<\/tr>\n<tr>\n<td>16:50 \u00e0s 17:10<\/td>\n<td style=\"text-align: left;\"><strong>Which records in the database can influence our clinical practice?<\/strong><br>Palestrante: Victor Verwaal (Su\u00e9cia)<\/td>\n<\/tr>\n<tr>\n<td>17:10 \u00e0s 17:30<\/td>\n<td style=\"text-align: left;\"><strong>French Experience: RENAPE and Big Renape<\/strong><br>Palestrante: Laurent Villeneuve (Fran\u00e7a)<\/td>\n<\/tr>\n<tr>\n<td>17:30 \u00e0s 17:50<\/td>\n<td style=\"text-align: left;\"><strong>Video on carcinomatosis: cytoreduction and HIPEC<\/strong><br>Palestrante: Francisco Izquierdo Mart\u00ednez (Chile)<\/td>\n<\/tr>\n<tr>\n<td>17:50 \u00e0s 18:10<\/td>\n<td style=\"text-align: left;\"><strong>Intraperitoneal chemotherapy regimens: future perspectives!<br><\/strong>Speaker: Paul Sugarbaker (USA)<strong><br><\/strong><\/td>\n<\/tr>\n<tr>\n<td>18:10<\/td>\n<td style=\"text-align: left;\"><strong>Closing<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-beb07e6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"beb07e6\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5e16162\" data-id=\"5e16162\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-262fd05 elementor-widget elementor-widget-text-editor\" data-id=\"262fd05\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u00daltima atualiza\u00e7\u00e3o: 09\/09\/2022 &#8211; 11:00<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Programa\u00e7\u00e3o Audit\u00f3rio Principal 30 de outubro 31 de outubro 1\u00ba de novembro 30 de outubro SESS\u00c3O: BASES TE\u00d3RICAS DO TRATAMENTO DAS CARCINOMATOSES PERITONEAIS Moderador: Carlos Humberto<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-919","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/wp-json\/wp\/v2\/pages\/919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/wp-json\/wp\/v2\/comments?post=919"}],"version-history":[{"count":172,"href":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/wp-json\/wp\/v2\/pages\/919\/revisions"}],"predecessor-version":[{"id":1613,"href":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/wp-json\/wp\/v2\/pages\/919\/revisions\/1613"}],"wp:attachment":[{"href":"https:\/\/latinoamericanoperitoneal.santacasa.org.br\/en\/wp-json\/wp\/v2\/media?parent=919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}